Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
NCT05406479
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
313
Enrollment
OTHER
Sponsor class
Conditions
Leprosy
Interventions
DRUG:
BE-PEP (Bedaquiline)
DRUG:
SDR-PEP
DRUG:
BE-PEP (Rifampicine)
Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
[object Object]